Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Not applicableActive Not RecruitingNCT05782400
What this trial is testing

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Testing effectiveness (Phase 2)UnknownNCT00027664
What this trial is testing

Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK 90
Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Testing effectiveness (Phase 2)Ended earlyNCT03562507
What this trial is testing

Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Metastatic
University of Michigan Rogel Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Very early researchStudy completedNCT02626130
What this trial is testing

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT03775850
What this trial is testing

EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Who this might be right for
Colorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
Evelo Biosciences, Inc. 69
Not applicableStudy completedNCT04873180
What this trial is testing

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 40
Post-approval studies (Phase 4)Ended earlyNCT00352859
What this trial is testing

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Who this might be right for
Carcinoma, Renal Cell
Bayer 2
Testing effectiveness (Phase 2)Ended earlyNCT02782715
What this trial is testing

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
University of Wisconsin, Madison 3
Early research (Phase 1)Ended earlyNCT02410174
What this trial is testing

To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors

Who this might be right for
Primary TumorRenal Cell Carcinoma
Beth Israel Medical Center 3
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288
What this trial is testing

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Not applicableStudy completedNCT05410509
What this trial is testing

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Who this might be right for
Renal Cell Carcinoma (RCC)
University of Alabama at Birmingham 25
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Study completedNCT00012337
What this trial is testing

ZD 1839 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT04919122
What this trial is testing

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Duke University 468
Next Page